We are live on ! Find out more
FF

FourThought Financial Portfolio holdings

AUM $677M
1-Year Est. Return 12.73%
This Fund
S&P 500
This Quarter Est. Return
-0.6%
1 Year Est. Return
-12.73%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$749M
AUM Growth
+$1.2M
Cap. Flow
+$9.42M
Cap. Flow %
1.26%
Top 10 Hldgs %
22.34%
Holding
1,613
New
79
Increased
366
Reduced
432
Closed
59

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$3.32M
2
NKE icon
Nike
NKE
+$3.08M
3
EBS icon
Emergent Biosolutions
EBS
+$2.22M
4
T icon
AT&T
T
+$2.07M
5
INTU icon
Intuit
INTU
+$1.27M

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 11.91%
3 Healthcare 11.46%
4 Consumer Discretionary 8.35%
5 Consumer Staples 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KTOS icon
801
Kratos Defense & Security Solutions
KTOS
$9.23B
$34K ﹤0.01%
1,524
+47
+3% +$1.16K
LUNG icon
802
Pulmonx
LUNG
$89.5M
$34K ﹤0.01%
972
+52
+6% +$2.05K
MKTX icon
803
MarketAxess Holdings
MKTX
$5.71B
$34K ﹤0.01%
83
-10
-11% -$4.59K
MLM icon
804
Martin Marietta Materials
MLM
$32.6B
$34K ﹤0.01%
100
PEN icon
805
Penumbra
PEN
$12.7B
$34K ﹤0.01%
129
PSCT icon
806
Invesco S&P SmallCap Information Technology ETF
PSCT
$510M
$34K ﹤0.01%
750
-39
-5% -$1.84K
RNG icon
807
RingCentral
RNG
$4.81B
$34K ﹤0.01%
159
+60
+61% +$15.2K
RWL icon
808
Invesco S&P 500 Revenue ETF
RWL
$9.78B
$34K ﹤0.01%
469
TWST icon
809
Twist Bioscience
TWST
$6.29B
$34K ﹤0.01%
322
+30
+10% +$3.44K
ATR icon
810
AptarGroup
ATR
$8.73B
$33K ﹤0.01%
280
CRI icon
811
Carter's
CRI
$1.47B
$33K ﹤0.01%
349
+2
+0.6% +$202
FXD icon
812
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$273M
$33K ﹤0.01%
+575
New +$35.1K
GNRC icon
813
Generac Holdings
GNRC
$11.9B
$33K ﹤0.01%
82
IJS icon
814
iShares S&P Small-Cap 600 Value ETF
IJS
$8.28B
$33K ﹤0.01%
330
LUXE
815
LuxExperience B.V.
LUXE
$1.13B
$33K ﹤0.01%
1,240
+6
+0.5% +$176
NEOG icon
816
Neogen
NEOG
$2.59B
$33K ﹤0.01%
777
+33
+4% +$1.44K
RLI icon
817
RLI Corp
RLI
$5.62B
$33K ﹤0.01%
662
SNX icon
818
TD Synnex
SNX
$20.3B
$33K ﹤0.01%
320
+94
+42% +$11.2K
STRO icon
819
Sutro Biopharma
STRO
$416M
$33K ﹤0.01%
176
+3
+2% +$570
UP icon
820
Wheels Up
UP
$227M
$33K ﹤0.01%
26
+1
+4% +$1.64K
HZNP
821
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$33K ﹤0.01%
302
-8
-3% -$831
EWC icon
822
iShares MSCI Canada ETF
EWC
$6.16B
$32K ﹤0.01%
905
FBT icon
823
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.71B
$32K ﹤0.01%
+195
New +$33.3K
FIBK icon
824
First Interstate BancSystem
FIBK
$3.75B
$32K ﹤0.01%
796
+723
+990% +$30.6K
MUB icon
825
iShares National Muni Bond ETF
MUB
$45.2B
$32K ﹤0.01%
277

Similar funds

FourThought Financial's Q3 2021 Portfolio in Review

As of Q3 2021, FourThought Financial held 1,613 positions worth $749M, up 0.16% from $747M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

FourThought Financial's Q3 2021 filing shows 79 new, 366 increased, 432 reduced and 59 closed positions. Its largest new stake was iShares 1-5 Year Investment Grade Corporate Bond ETF: 14,776 shares worth $807K. The largest sale was Alexion Pharmaceuticals, an estimated $3.32M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • FourThought Financial's largest Q3 2021 buy was iShares 1-5 Year Investment Grade Corporate Bond ETF: 14,776 shares worth $807K.
  • FourThought Financial added most to JPMorgan Ultra-Short Income ETF in Q3 2021, an estimated $4.59M increase.
  • FourThought Financial's biggest Q3 2021 reduction was Nike, cutting an estimated $3.08M.
  • FourThought Financial fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.32M.
  • FourThought Financial's ten largest holdings make up 22% of its $749M portfolio in Q3 2021.
  • FourThought Financial opened 79 new positions and closed 59 in Q3 2021.
  • FourThought Financial's portfolio value rose 0.16% quarter-over-quarter to $749M.

Based on FourThought Financial's 13F filing for Q3 2021, filed 12 Nov 2021.